Upgrade to SI Premium - Free Trial

Imprimis Pharma (IMMY) Reports Q4 Loss of $0.30

March 12, 2015 4:15 PM

Imprimis Pharma (NASDAQ: IMMY) reported Q4 EPS of ($0.30), versus ($0.21) reported last year.

For earnings history and earnings-related data on Imprimis Pharma (IMMY) click here.

Categories

Earnings

Next Articles